Literature DB >> 22532318

The prognosis of perihilar cholangiocarcinoma after radical treatments.

Luca Fabris, Domenico Alvaro.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22532318     DOI： 10.1002/hep.25808

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  9 in total

1.  Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Gaia Spagnuolo; Luisa Sambado; Stefano Indraccolo; Giorgia Nardo; Antonio Rosato; Simone Brivio; Chiara Caslini; Tommaso Stecca; Marco Massani; Nicolò Bassi; Eugenio Novelli; Carlo Spirli; Luca Fabris; Mario Strazzabosco
Journal:  Cancer Res       Date:  2016-06-21       Impact factor: 12.701

Review 2.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

3.  Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

Authors:  Massimiliano Cadamuro; Stuart Duncan Morton; Mario Strazzabosco; Luca Fabris
Journal:  Transl Gastrointest Cancer       Date:  2013-07

Review 4.  Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer.

Authors:  Sukanya Roy; Priyanka Banerjee; Burcin Ekser; Kayla Bayless; David Zawieja; Gianfranco Alpini; Shannon S Glaser; Sanjukta Chakraborty
Journal:  Am J Pathol       Date:  2021-09-09       Impact factor: 4.307

5.  Matrine induces RIP3-dependent necroptosis in cholangiocarcinoma cells.

Authors:  Beibei Xu; Minying Xu; Yuan Tian; Qiang Yu; Yujie Zhao; Xiong Chen; Panying Mi; Hanwei Cao; Bing Zhang; Gang Song; Yan-Yan Zhan; Tianhui Hu
Journal:  Cell Death Discov       Date:  2017-01-23

6.  Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5.

Authors:  Z Yu; H Cheng; H Zhu; M Cao; C Lu; S Bao; Y Pan; Y Li
Journal:  Braz J Med Biol Res       Date:  2017-08-17       Impact factor: 2.590

Review 7.  Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.

Authors:  Sukanya Roy; Shannon Glaser; Sanjukta Chakraborty
Journal:  Front Med (Lausanne)       Date:  2019-12-18

8.  Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma.

Authors:  Sukanya Roy; Subhashree Kumaravel; Priyanka Banerjee; Tori K White; April O'Brien; Catherine Seelig; Rahul Chauhan; Burcin Ekser; Kayla J Bayless; Gianfranco Alpini; Shannon S Glaser; Sanjukta Chakraborty
Journal:  Cells       Date:  2021-11-09       Impact factor: 7.666

Review 9.  Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  J Clin Med       Date:  2015-12-19       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.